These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18708058)

  • 1. Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2.
    Bhat KP; Pelloski CE; Zhang Y; Kim SH; deLaCruz C; Rehli M; Aldape KD
    FEBS Lett; 2008 Sep; 582(21-22):3193-200. PubMed ID: 18708058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
    Ashburner BP; Westerheide SD; Baldwin AS
    Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300.
    Hoberg JE; Popko AE; Ramsey CS; Mayo MW
    Mol Cell Biol; 2006 Jan; 26(2):457-71. PubMed ID: 16382138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J; Colburn NH
    Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.
    Liu Y; Smith PW; Jones DR
    Mol Cell Biol; 2006 Dec; 26(23):8683-96. PubMed ID: 17000776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of chemokine gene expression by hypoxia via cooperative activation of NF-kappaB and histone deacetylase.
    Safronova O; Pluemsampant S; Nakahama K; Morita I
    Int J Biochem Cell Biol; 2009 Nov; 41(11):2270-80. PubMed ID: 19446037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.
    Cicek M; Fukuyama R; Cicek MS; Sizemore S; Welch DR; Sizemore N; Casey G
    Clin Exp Metastasis; 2009; 26(3):229-37. PubMed ID: 19165610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB inhibits transcription of the H(+)-K(+)-ATPase alpha(2)-subunit gene: role of histone deacetylases.
    Zhang W; Kone BC
    Am J Physiol Renal Physiol; 2002 Nov; 283(5):F904-11. PubMed ID: 12372765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases.
    Kumar A; Lin Z; SenBanerjee S; Jain MK
    Mol Cell Biol; 2005 Jul; 25(14):5893-903. PubMed ID: 15988006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear corepressor is required for inhibition of phosphoenolpyruvate carboxykinase expression by tumor necrosis factor-alpha.
    Yan J; Gao Z; Yu G; He Q; Weng J; Ye J
    Mol Endocrinol; 2007 Jul; 21(7):1630-41. PubMed ID: 17456789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions.
    Miao F; Gonzalo IG; Lanting L; Natarajan R
    J Biol Chem; 2004 Apr; 279(17):18091-7. PubMed ID: 14976218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exchange of a nuclear corepressor between NF-kappaB and CREB mediates inhibition of phosphoenolpyruvate carboxykinase transcription by NF-kappaB.
    Yan JH; Gao ZG; Ye JP; Weng JP
    Chin Med J (Engl); 2010 Jan; 123(2):221-6. PubMed ID: 20137375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression.
    Aguilera C; Hoya-Arias R; Haegeman G; Espinosa L; Bigas A
    Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16537-42. PubMed ID: 15536134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RelB/p50 complexes regulate cytokine-induced YKL-40 expression.
    Bhardwaj R; Yester JW; Singh SK; Biswas DD; Surace MJ; Waters MR; Hauser KF; Yao Z; Boyce BF; Kordula T
    J Immunol; 2015 Mar; 194(6):2862-70. PubMed ID: 25681350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-kappaB and histone deacetylase 1 in ventricular myocytes.
    Shaw J; Zhang T; Rzeszutek M; Yurkova N; Baetz D; Davie JR; Kirshenbaum LA
    Circ Res; 2006 Dec; 99(12):1347-54. PubMed ID: 17082476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
    Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
    EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter.
    Jamaluddin M; Choudhary S; Wang S; Casola A; Huda R; Garofalo RP; Ray S; Brasier AR
    J Virol; 2005 Dec; 79(24):15302-13. PubMed ID: 16306601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells.
    Batra S; Sahu RP; Kandala PK; Srivastava SK
    Mol Cancer Ther; 2010 Jun; 9(6):1596-608. PubMed ID: 20484017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
    Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
    Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.